News from us and our partners

Tags

Topics

0 results

News
29 May, 2015
Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8®
News
20 May, 2015
Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease
News
4 May, 2015
Stentys' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan
News
28 April, 2015
Pixium Vision announces the publication of PRIMA results, a wireless subretinal implant, in Nature Medicine
News
27 April, 2015
MedDay reports positive pivotal Phase III study results with MD1003 in patients with Progressive Multiple Sclerosis
News
20 April, 2015
MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint
News
20 April, 2015
Lysogene appoints Annette Clancy as chair of the board
News
27 March, 2015
Cellucomp Plant Opened by Annabelle Ewing MSP
News
26 February, 2015
ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014
News
26 February, 2015
Lysogène, University of Massachusetts Medical School and Auburn Unniversity announce collaboration agreement
News
25 February, 2015
Comet Biorefining Secures Funding Led By Sofinnova Partners
News
11 February, 2015
Sofinnova Partners’ portfolio company GlycoVaxyn sold to GlaxoSmithKline for $212 M in an all-cash deal
News
3 February, 2015
Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
News
3 February, 2015
Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
News
26 January, 2015
Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen
News
26 January, 2015
Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen

Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8®

Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease

Stentys' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan

Pixium Vision announces the publication of PRIMA results, a wireless subretinal implant, in Nature Medicine

MedDay reports positive pivotal Phase III study results with MD1003 in patients with Progressive Multiple Sclerosis

MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint

Lysogene appoints Annette Clancy as chair of the board

Cellucomp Plant Opened by Annabelle Ewing MSP

ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014

Lysogène, University of Massachusetts Medical School and Auburn Unniversity announce collaboration agreement

Comet Biorefining Secures Funding Led By Sofinnova Partners

Sofinnova Partners’ portfolio company GlycoVaxyn sold to GlaxoSmithKline for $212 M in an all-cash deal

Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen

Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen